Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126000292 | 12600029 | 2 | F | 201606 | 20160909 | 20160727 | 20160915 | EXP | DE-UCBSA-2016027362 | UCB | 0.00 | A | M | Y | 113.00000 | KG | 20160916 | MD | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126000292 | 12600029 | 1 | PS | Certolizumab pegol | CERTOLIZUMAB PEGOL | 1 | Subcutaneous | 200 MG, EV 2 WEEKS(QOW) | Y | U | 125160 | 200 | MG | QOW | |||||
| 126000292 | 12600029 | 2 | SS | CELEBREX | CELECOXIB | 1 | UNK UNK, AS NEEDED (PRN) | U | U | 0 | |||||||||
| 126000292 | 12600029 | 3 | C | GABAPENTIN. | GABAPENTIN | 1 | Oral | 300 MG, 3X/DAY (TID) | U | 0 | 300 | MG | TID | ||||||
| 126000292 | 12600029 | 4 | C | Novaminsulfon | METAMIZOLE | 1 | Oral | 30, AS NEEDED (PRN) | U | 0 | |||||||||
| 126000292 | 12600029 | 5 | C | PREGABALIN. | PREGABALIN | 1 | Oral | 50 MG, 3X/DAY (TID) | U | 0 | 50 | MG | TID | ||||||
| 126000292 | 12600029 | 6 | C | MOVICOL | POLYETHYLENE GLYCOL 3350POTASSIUM CHLORIDESODIUM BICARBONATESODIUM CHLORIDE | 1 | UNK, AS NEEDED (PRN) | U | 0 | ||||||||||
| 126000292 | 12600029 | 7 | C | Circadin | MELATONIN | 1 | 4 MG, ONCE DAILY (QD) (STRENGTH 2 MG) | U | 0 | 4 | MG | QD | |||||||
| 126000292 | 12600029 | 8 | C | NOVALGIN | METAMIZOLE SODIUM | 1 | (STRENGTH 500), AS NEEDED (PRN) | U | 0 | ||||||||||
| 126000292 | 12600029 | 9 | C | MELOXICAM. | MELOXICAM | 1 | UNK | U | 0 | ||||||||||
| 126000292 | 12600029 | 10 | C | OTRIVIN | XYLOMETAZOLINE | 1 | STRENGTH 0.1%, 3X/DAY (TID) | U | 0 | NASAL DROPS | TID | ||||||||
| 126000292 | 12600029 | 11 | C | Dolantin | MEPERIDINE | 1 | U | 0 | |||||||||||
| 126000292 | 12600029 | 12 | C | Tilidin | NALOXONE HYDROCHLORIDETILIDINE HYDROCHLORIDE | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126000292 | 12600029 | 1 | Ankylosing spondylitis |
| 126000292 | 12600029 | 2 | Product used for unknown indication |
| 126000292 | 12600029 | 3 | Product used for unknown indication |
| 126000292 | 12600029 | 4 | Product used for unknown indication |
| 126000292 | 12600029 | 5 | Product used for unknown indication |
| 126000292 | 12600029 | 6 | Product used for unknown indication |
| 126000292 | 12600029 | 7 | Product used for unknown indication |
| 126000292 | 12600029 | 8 | Analgesic therapy |
| 126000292 | 12600029 | 9 | Product used for unknown indication |
| 126000292 | 12600029 | 10 | Product used for unknown indication |
| 126000292 | 12600029 | 11 | Product used for unknown indication |
| 126000292 | 12600029 | 12 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126000292 | 12600029 | HO |
| 126000292 | 12600029 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126000292 | 12600029 | Headache | |
| 126000292 | 12600029 | Normochromic normocytic anaemia | |
| 126000292 | 12600029 | Pancreatitis acute | |
| 126000292 | 12600029 | Sinusitis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126000292 | 12600029 | 1 | 20160407 | 2016 | 0 |